Showing results (81-90 of 231) with videos related to

Sort By:
Pageof 24
International Journal of Molecular Sciences|September 28, 2021
Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid BiopsyDaniel A Balikov, Kevin Hu, Chia-Jen Liu, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Detection of somatic copy number alterations in cancer using targeted exome capture sequencingRobert J Lonigro, Catherine S Grasso, Dan R Robinson, et al.
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White AmericansKazutaka Nanba, Kei Omata, Tobias Else, et al.
Cancer Research|June 17, 2011
TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancersRam-Shankar Mani, Matthew K Iyer, Qi Cao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2007
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancerRohit Mehra, Scott A Tomlins, Ronglai Shen, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2020
Somatic <i>CACNA1H</i> Mutation As a Cause of Aldosterone-Producing AdenomaKazutaka Nanba, Amy R Blinder, Juilee Rege, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 18, 2020
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomasNoah A Brown, Komal R Plouffe, Osman Yilmaz, et al.
Science Translational Medicine|March 4, 2011
Therapeutic targeting of SPINK1-positive prostate cancerBushra Ateeq, Scott A Tomlins, Bharathi Laxman, et al.
European Urology Focus|February 10, 2018
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk CalculatorDonna P Ankerst, Martin Goros, Scott A Tomlins, et al.
The American Journal of Pathology|February 26, 2004
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancerChandan Kumar-Sinha, Rajal B Shah, Bharathi Laxman, et al.
Pageof 24